Enterprise Value
11.73M
Cash
80.33M
Avg Qtr Burn
-8.859M
Short % of Float
2.05%
Insider Ownership
6.69%
Institutional Own.
60.93%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Nana-val (nanatinostat + valganciclovir) Details Cancer, Lymphoma Big Mover™ Suspected Mover™ Susp. Mover™ | Phase 3 Data readout | |
Phase 1b Data readout |